Changes to the website
Sponsored By
AbbVie
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4860

Next 25
Website Changes
09/26/2016 Orbus Therapeutics Announces Enrollment of First Patient in Phase 3 Trial in Late-Stage Brain Cancer
09/21/2016 The Clinical Implications of Inconsistently Methylated Results from Glioblastoma MGMT Testing by Replicate Methylation-Specific PCR.
09/19/2016 CNS Oncology Publishes Tumor Treating Fields Treatment Planning and Patient Follow-up Guidelines in Glioblastoma
09/19/2016 Brain cancer replaces leukemia as deadliest cancer for kids, study shows
09/13/2016 The CERN Foundation recently completed the second edition of their Ependymoma Guide
09/08/2016 Monteris Medical Receives IDE Approval From FDA To Evaluate NeuroBlate® In Patients Newly Diagnosed With Glioblastoma Multiforme
09/08/2016 Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1a/PKM2 axis in glioblastoma cells.
09/07/2016 DelMar Pharmaceuticals and Accurexa to Collaborate in the Development of a Novel Combination Chemotherapy for the Local Treatment of Brain Cancer
09/07/2016 NY Islanders fundraiser for Brain Tumor Research!
09/07/2016 The fourth weapon in the battle against cancer
09/01/2016 Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
09/01/2016 Biological effect of an alternating electric field on cell proliferation and synergistic antimitotic effect in combination with ionizing radiation.
09/01/2016 Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis.
08/31/2016 Musella Foundation Copay Assistance Program reopens!
08/31/2016 Immunotherapy, Vaccines Offer Promise in Glioblastoma, But Data is Still Preliminary
08/31/2016 Kadmon launches mid-stage study of lead oncology candidate in brain cancer
08/25/2016 NY Islanders fundraiser for Brain Tumor Research!
08/24/2016 Update published for "Treatment Options For Glioblastoma and other Glioma"
08/23/2016 Curcumin Changes the Polarity of Tumor-Associated Microglia and Eliminates Glioblastoma.
08/18/2016 Tamoxifen Induces Cytotoxic Autophagy in Glioblastoma.
08/18/2016 Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma.
08/18/2016 Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients.
08/16/2016 Novocure Converts More Than 500 U.S. Patients to Second Generation Optune within Four Weeks of FDA Approval on July 13
08/13/2016 MANY CANCER PATIENTS MUST FACE BANKRUPTCY—OR DIE
08/10/2016 Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2016 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites